Part 1 | The landscape
Trial activity against live programmes
Each bubble is a large developer. Trial count measures activity since 2014; verified programmes show what is still active today. Select a bubble to see that company's pipeline below.
Bubble size: novel-segment programmes
Industry-sponsored Phase 1 to 4 interventional trials, start dates 1 January 2014 to 22 October 2026. J&J and Takeda show trial history but no verified active programmes.
Part 2 | The pipeline
Every verified programme, by phase
Filter by developer, segment or pathogen. Drag the phase scrubber to narrow the stages shown, or play the tracker to see how the pipeline we follow has grown. Select a programme for its profile.
In the licensed database
- Verification sources and dates
- Linked trial registrations
- Analyst notes and change history
- Competing programmes in this pathogen
Want the full pipeline database?
The licensed workbook includes more than 2,000 industry trials, small and medium developers, preclinical programmes, mRNA platform analysis and the October 2026 change log, with a briefing call.
Request pricing and a briefing